We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+24.38%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.87B
AUM Growth
+$571M
Cap. Flow
-$98.3M
Cap. Flow %
-2.54%
Top 10 Hldgs %
18.79%
Holding
1,345
New
153
Increased
459
Reduced
571
Closed
93

Top Buys

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$10.6M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$8.91M
3
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$7.53M
4
VCIT icon
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
+$6.42M
5
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$6.23M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$21.5M
2
MSFT icon
Microsoft
MSFT
+$18M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$12.3M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$7.25M
5
SPYD icon
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
+$6.47M

Sector Composition

Rank Sector Weight
1 Technology 18.06%
2 Healthcare 12.66%
3 Financials 10.15%
4 Consumer Discretionary 9.43%
5 Communication Services 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLGL icon
1201
Sol-Gel Technologies
SLGL
$277M
$103K ﹤0.01%
+1,150
New +$93.1K
AMRS
1202
DELISTED
Amyris Inc.
AMRS
$103K ﹤0.01%
24,100
+10,100
+72% +$33.6K
GEG icon
1203
Great Elm Group
GEG
$67.4M
$100K ﹤0.01%
42,865
– –
HGLB
1204
Highland Global Allocation Fund
HGLB
$177M
$97K ﹤0.01%
+15,000
New +$85.1K
CLVS
1205
DELISTED
Clovis Oncology, Inc.
CLVS
$97K ﹤0.01%
14,300
-9,535
-40% -$72.2K
TCRT icon
1206
Alaunos Therapeutics
TCRT
$4.84M
$96K ﹤0.01%
193
– –
GRCE
1207
Grace Therapeutics
GRCE
$34.3M
$93K ﹤0.01%
4,133
– –
CNR
1208
DELISTED
Cornerstone Building Brands, Inc.
CNR
$91K ﹤0.01%
15,000
– –
ICMB icon
1209
Investcorp Credit Management BDC
ICMB
$11.9M
$90K ﹤0.01%
25,715
-180
-0.7% -$692
AMC icon
1210
AMC Entertainment Holdings
AMC
$2.16B
$87K ﹤0.01%
2,029
-1,065
-34% -$46.6K
SHO icon
1211
Sunstone Hotel Investors
SHO
$2.01B
$85K ﹤0.01%
10,404
– –
RUTH
1212
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$82K ﹤0.01%
+10,000
New +$87.2K
ATYR
1213
aTyr Pharma
ATYR
$51.9M
$81K ﹤0.01%
18,343
-598
-3% -$2.17K
ENLC
1214
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$81K ﹤0.01%
33,057
-13,973
-30% -$28.9K
PVLA
1215
Palvella Therapeutics
PVLA
$2.19B
$77K ﹤0.01%
310
-61
-16% -$14.3K
DCF
1216
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$77K ﹤0.01%
+10,095
New +$72.7K
JRS icon
1217
Nuveen Real Estate Income Fund
JRS
$244M
$75K ﹤0.01%
10,018
-1,541
-13% -$11.2K
PSEC icon
1218
Prospect Capital
PSEC
$1.15B
$75K ﹤0.01%
14,590
-3,100
-18% -$14.5K
FEI
1219
DELISTED
FIRST TRUST MLP AND ENERGY INCOME FUND
FEI
$75K ﹤0.01%
+13,339
New +$76.6K
JMM icon
1220
Nuveen Multi-Market Income Fund
JMM
$55.2M
$73K ﹤0.01%
10,650
+150
+1% +$980
VNRX icon
1221
VolitionRx Ltd
VNRX
$9.24M
$73K ﹤0.01%
939
+291
+45% +$21K
CBUS icon
1222
Cibus
CBUS
$146M
$70K ﹤0.01%
284
– –
LRFC
1223
DELISTED
Logan Ridge Finance Corp
LRFC
$70K ﹤0.01%
4,444
– –
AGRX
1224
DELISTED
Agile Therapeutics
AGRX
$70K ﹤0.01%
+13
New +$67.5K
HLX icon
1225
Helix Energy Solutions
HLX
$1.47B
$69K ﹤0.01%
20,000
– –
47 48
49
50 51

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Oppenheimer & Co held 1,345 positions worth $3.87B, up 17% from $3.29B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q2 2020 filing shows 153 new, 459 increased, 571 reduced and 93 closed positions. Its largest new stake was Chegg: 80,419 shares worth $5.41M. The largest sale was Invesco QQQ Trust, an estimated $21.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2020 buy was Chegg: 80,419 shares worth $5.41M.
  • Oppenheimer & Co added most to ProShares Short S&P500 in Q2 2020, an estimated $10.6M increase.
  • Oppenheimer & Co's biggest Q2 2020 reduction was Invesco QQQ Trust, cutting an estimated $21.5M.
  • Oppenheimer & Co fully exited State Street SPDR Portfolio S&P 500 High Dividend ETF in Q2 2020, selling an estimated $6.47M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $3.87B portfolio in Q2 2020.
  • Oppenheimer & Co opened 153 new positions and closed 93 in Q2 2020.
  • Oppenheimer & Co's portfolio value rose 17% quarter-over-quarter to $3.87B.

Based on Oppenheimer & Co's 13F filing for Q2 2020, filed 11 Aug 2020.